The administration of recombinant Irisin to 14-month-old mice over a four-month period reduced atrophic and inflammatory gene expression while enhancing muscle weight and grip strength, indicating that Irisin can effectively mitigate age-associated sarcopenia [21]. Here, FNDC5 is linked to sarcopenia.